https://www.selleckchem.com/products/mv1035.html
Hence, 17 500 AAV patients (GPA and MPA) are estimated to live in Germany, with an annual increase of 3,200 patients. According to their demographic and disease specific characteristics, AAV patients identified in this claims data approach are representative. This is the first study using claims data to assess the epidemiology of AAV. In Germany, AAV was diagnosed more frequently than it was estimated by previous self-reporting registry-based studies. The findings indicate that epidemiological data of AAV may have been underestimated but
Like
Comment
Share
